Table of Contents:
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH
3 MARKET DYNAMICS
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 MATERIAL MIX CHANGES PROVIDING OPPORTUNITIES FOR NEW PLAYERS
3.2.2 INCREASE IN GLOBAL DEMAND FOR POINT OF CARE TESTING
3.2.3 MICROFLUIDIC TECHNOLOGIES FOR MINIATURIZATION OF CHIP
3.2.4 RISING DEMAND IN GENOMICS AND PROTEOMICS STUDIES
3.3 RESTRAINTS
3.3.1 GEOMETRICAL AND SURFACE CHEMISTRY ISSUES
3.3.2 ADHERENCE TO STRINGENT REGULATORY REQUIREMENTS
3.4 OPPORTUNITIES
3.4.1 NEW PRODUCT INNOVATIONS
3.4.2 RISE IN PARTNERSHIPS AND COLLABORATIONS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
4.7 COMPETITIVE POSITIONING OF KEY COMPETITORS AND MARKET SHARE ANALYSIS
5 GLOBAL MICROFLUIDIC DEVICES MARKET, BY INDUSTRY
5.1 IN-VITRO DIAGNOSTICS (IVD)
5.2 PHARMACEUTICAL
5.3 MEDICAL DEVICES
6 GLOBAL MICROFLUIDIC DEVICES MARKET, BY MATERIAL
6.1 POLYMER
6.2 GLASS
6.3 SILICON
7 GLOBAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION
7.1 PHARMACEUTICAL AND LIFE SCIENCE RESEARCH
7.2 CLINICAL AND VETERINARY DISGNOSTICS
7.3 POINT OF CARE
7.4 ANALYTICAL DEVICES
7.5 DRUG DELIVERY
7.6 ENVIRONMENTAL AND INDUSTRIAL APPLICATIONS
8 GLOBAL MICROFLUIDIC DEVICES MARKET, BY REGION
8.1 North America
8.1.1 INTRODUCTION
8.2 EUROPE
8.2.1 INTRODUCTION
8.3 ASIA
8.3.1 INTRODUCTION
9 GLOBAL MICROFLUIDIC DEVICES MARKET: COMPANY PROFILE
9.1 F. HOFFMANN-LA ROCHE AG
9.1.1 BUSINESS OVERVIEW
9.1.2 PRODUCT PORTFOLIO
9.1.3 KEY DEVELOPMENTS
9.1.4 CONTACT DETAILS
9.2 ABBOTT LABORATORIES
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCT PORTFOLIO
9.2.3 KEY DEVELOPMENTS
9.2.4 CONTACT DETAILS
9.3 SIEMENS HEALTHCARE GMBH
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCT PORTFOLIO
9.3.3 KEY DEVELOPMENTS
9.3.4 CONTACT DETAILS
9.4 AGILENT TECHNOLOGIES, INC
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCT PORTFOLIO
9.4.3 KEY DEVELOPMENTS
9.4.4 CONTACT DETAILS
9.5 FLUIDIGM CORPORATION
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCT PORTFOLIO
9.5.3 KEY DEVELOPMENTS
9.5.4 CONTACT DETAILS
9.6 BIO-RAD LABORATORIES, INC.
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCT PORTFOLIO
9.6.3 KEY DEVELOPMENTS
9.6.4 CONTACT DETAILS
9.7 CEPHEID
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCT PORTFOLIO
9.7.3 KEY DEVELOPMENTS
9.7.4 CONTACT DETAILS
9.8 RAINDANCE TECHNOLOGIES, INC
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCT PORTFOLIO
9.8.3 KEY DEVELOPMENTS
9.8.4 CONTACT DETAILS
9.9 DOLOMITE CENTRE
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCT PORTFOLIO
9.9.3 KEY DEVELOPMENTS
9.9.4 CONTACT DETAILS
9.10 MICRONIT MICROFLUIDICS
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCT PORTFOLIO
9.10.3 KEY DEVELOPMENTS
9.10.4 CONTACT DETAILS
9.11 JOHNSON & JOHNSON
9.11.1 BUSINESS OVERVIEW
9.11.2 PRODUCT PORTFOLIO
9.11.3 KEY DEVELOPMENTS
9.11.4 CONTACT DETAILS
9.12 BECTON, DICKINSON AND COMPANY
9.12.1 BUSINESS OVERVIEW
9.12.2 PRODUCT PORTFOLIO
9.12.3 KEY DEVELOPMENTS
9.12.4 CONTACT DETAILS
